Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Irish Medical Journal
|
May 25, 2019
Weight Status in Children with Autism Spectrum Disorder
L McCarron, M Fitzgerald, S Gallagher, et al.
Clinical Laboratory
|
June 29, 2016
Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
Stephen E Langabeer, Sarah L McCarron, Karl Haslam, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology
|
December 21, 2012
The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics
Sarah L McCarron, Karl Haslam, Mireille Crampe, et al.
Genetic Testing and Molecular Biomarkers
|
January 8, 2013
BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients
Sarah L McCarron, Lisa M O'Connor, Stephen E Langabeer, et al.
International Journal of Laboratory Hematology
|
June 23, 2011
A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia
S L McCarron, K Haslam, J Kelly, et al.
International Journal of Cancer
|
October 2, 2003
EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma
Sarah L McCarron, Adrian C Bateman, Jeffrey M Theaker, et al.
Pain
|
July 24, 2020
Patients' experience with and perspectives on neuromodulation for pain: a systematic review of the qualitative research literature
Tamara L McCarron, Gail MacKean, Laura E Dowsett, et al.
Case Reports in Hematology
|
October 11, 2013
Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
Sarah L McCarron, Karena Maher, Johanna Kelly, et al.
Bone Marrow Transplantation
|
March 12, 2014
The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT
S E Langabeer, S L McCarron, K Haslam, et al.
Leukemia Research
|
June 7, 2011
Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia
Stephen E Langabeer, Sarah L McCarron, Peig Carroll, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Irish Medical Journal
|
May 25, 2019
Weight Status in Children with Autism Spectrum Disorder
L McCarron, M Fitzgerald, S Gallagher, et al.
Clinical Laboratory
|
June 29, 2016
Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
Stephen E Langabeer, Sarah L McCarron, Karl Haslam, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology
|
December 21, 2012
The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics
Sarah L McCarron, Karl Haslam, Mireille Crampe, et al.
Genetic Testing and Molecular Biomarkers
|
January 8, 2013
BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients
Sarah L McCarron, Lisa M O'Connor, Stephen E Langabeer, et al.
International Journal of Laboratory Hematology
|
June 23, 2011
A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia
S L McCarron, K Haslam, J Kelly, et al.
International Journal of Cancer
|
October 2, 2003
EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma
Sarah L McCarron, Adrian C Bateman, Jeffrey M Theaker, et al.
Pain
|
July 24, 2020
Patients' experience with and perspectives on neuromodulation for pain: a systematic review of the qualitative research literature
Tamara L McCarron, Gail MacKean, Laura E Dowsett, et al.
Case Reports in Hematology
|
October 11, 2013
Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
Sarah L McCarron, Karena Maher, Johanna Kelly, et al.
Bone Marrow Transplantation
|
March 12, 2014
The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT
S E Langabeer, S L McCarron, K Haslam, et al.
Leukemia Research
|
June 7, 2011
Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia
Stephen E Langabeer, Sarah L McCarron, Peig Carroll, et al.
Page
of 5